Cwm Taf University Health Board (NHS)
17
1
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
ASPIRE II. Supporting Antibiotic Stewardship in Primary Care Via POCT
Role: collaborator
The Impact of Probiotic Supplementation on General Well Being
Role: lead
ASPIRE I: Supporting Antibiotic Stewardship in Primary Care Via POCT
Role: collaborator
Best Start - Weight Management During Pregnancy
Role: lead
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
Role: lead
Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes
Role: lead
The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.
Role: lead
Characterisation of the Immune Response to SARS-CoV-2 / COVID-19
Role: lead
Mycoplasma Species and the Genitourinary System
Role: lead
Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health
Role: collaborator
Exploring Breathing Patterns
Role: lead
Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema
Role: lead
Prompting And encouRaging Community Hydration Through EDucation
Role: lead
UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections
Role: lead
Clozapine Induced Weight Gain
Role: lead
Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema
Role: collaborator
A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors
Role: collaborator
All 17 trials loaded